In interviews at OIS@AAO, we talk with Robert Dempsey, global head of Shire’s ophthalmic business, about the international launch of Xiidra. Joseph Boorady, OD, CEO and president of TearScience, lays out the company’s plans since being acquired by Johnson & Johnson Vision. Finally, Tom Gadek, president and CEO of TearSolutions, explains how he’s hoping to score another winning dry eye treatment with a start-up.
Meet Our Host
Joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.